R. Heyrman

发表

Long‐Term Efficacy and Safety of Triple‐Combination Therapy With Olmesartan Medoxomil and Amlodipine Besylate and Hydrochlorothiazide for Hypertension

S. Oparil, J. Izzo, D. Kereiakes, 2012, Journal of clinical hypertension.

Pharmacokinetics of Amlodipine and Olmesartan After Administration of Amlodipine Besylate and Olmesartan Medoxomil in Separate Dosage Forms and as a Fixed‐Dose Combination

M. Bathala, M. Shenouda, S. Rohatagi, 2008, Journal of clinical pharmacology.

Biocompatibility of a Polycarbonate Membrane

W. Backer, Marc E. De Broe, Jean-Pierre van Waeleghem, 1986 .

Olmesartan/amlodipine/hydrochlorothiazide in participants with hypertension and diabetes, chronic kidney disease, or chronic cardiovascular disease: a subanalysis of the multicenter, randomized, double-blind, parallel-group TRINITY study

J. Izzo, D. Kereiakes, M. Melino, 2012, Cardiovascular Diabetology.

Bioabsorbable Intracoronary Matrix for Prevention of Ventricular Remodeling After Myocardial Infarction.

Sunil V. Rao, T. Henry, M. Krucoff, 2016, Journal of the American College of Cardiology.

A randomized, double-blind, placebo-controlled trial to evaluate the safety and effectiveness of intracoronary application of a novel bioabsorbable cardiac matrix for the prevention of ventricular remodeling after large ST-segment elevation myocardial infarction: Rationale and design of the PRESERVA

Sunil V. Rao, M. Krucoff, P. Douglas, 2015, American heart journal.

Effect of oxygen administration on the breathing pattern during haemodialysis in man.

W. De Backer, M. D. de Broe, J. Van Waeleghem, 1989, The European respiratory journal.

Ventilation and breathing patterns during hemodialysis-induced carbon dioxide unloading.

W. De Backer, M. D. de Broe, J. Van Waeleghem, 1987, The American review of respiratory disease.

Long-term efficacy of a combination of amlodipine and olmesartan medoxomil±hydrochlorothiazide in patients with hypertension stratified by age, race and diabetes status: a substudy of the COACH trial

S. Oparil, M. Melino, S. Chrysant, 2010, Journal of Human Hypertension.

The triple neurokinin-receptor antagonist CS-003 inhibits neurokinin A-induced bronchoconstriction in patients with asthma.

R. Pauwels, G. Joos, R. Louis, 2006, Pulmonary pharmacology & therapeutics.

Pathogenesis of dialysis-induced hypoxemia: a short overview.

W. De Backer, M. D. de Broe, G. Verpooten, 1988, Kidney international. Supplement.

Model‐Supported Development of CS‐8635: A Fixed‐Dose Combination of Olmesartan, Amlodipine, and Hydrochlorothiazide

Raymond Miller, Helen Moore, S. Rohatagi, 2013, Clinical pharmacology in drug development.

Triple-Combination Therapy with Olmesartan, Amlodipine, and Hydrochlorothiazide in Black and Non-Black Study Participants with Hypertension

S. Oparil, D. Kereiakes, M. Melino, 2012, American Journal of Cardiovascular Drugs.

A study in patients with erectile dysfunction comparing different formulations of prostaglandin E1. Alprostadil Study Group.

D. Vanderschueren, R. Heyrman, E. Keogh, 1995, The Journal of urology.

Combined Olmesartan, Amlodipine, and Hydrochlorothiazide Therapy in Randomized Patients with Hypertension: A Subgroup Analysis of the TRINITY Study by Age

J. Izzo, A. Lewin, M. Melino, 2013, Drugs & Aging.

Triple therapy with olmesartan medoxomil, amlodipine besylate, and hydrochlorothiazide in adult patients with hypertension: The TRINITY multicenter, randomized, double-blind, 12-week, parallel-group study.

S. Oparil, M. Melino, James Lee, 2010, Clinical therapeutics.

The TRINITY Study: distribution of systolic blood pressure reductions

M. Melino, S. Chrysant, James Lee, 2013, Integrated blood pressure control.

Pharmacokinetics of Olmesartan Medoxomil in Pediatric Patients with Hypertension

D. Blowey, J. Blumer, J. Sullivan, 2012, Pediatric Drugs.

Pharmacokinetics of olmesartan medoxomil in pediatric patients with hypertension.

D. Blowey, J. Blumer, J. Sullivan, 2012, Paediatric drugs.

The Use of Modeling and Simulation to Guide Clinical Development of Olmesartan Medoxomil in Pediatric Subjects

D. R. Wada, S. Rohatagi, D. Salazar, 2012, Clinical pharmacology and therapeutics.

A Double-Blind, Dose-Response Study of the Efficacy and Safety of Olmesartan Medoxomil in Children and Adolescents with Hypertension

R. Heyrman, K. Miyazaki, A. Bhorat, 2010, Hypertension.

Olmesartan/Amlodipine/Hydrochlorothiazide in Obese Participants With Hypertension: A TRINITY Subanalysis

S. Oparil, M. Melino, James Lee, 2013, Journal of clinical hypertension.

Triple-Combination therapy with olmesartan, amlodipine, and hydrochlorothiazide in black and non-black study participants with hypertension: the TRINITY randomized, double-blind, 12-week, parallel-group study.

S. Oparil, J. Izzo, D. Kereiakes, 2012, American journal of cardiovascular drugs : drugs, devices, and other interventions.

Efficacy and Safety of Long‐Term Treatment With the Combination of Amlodipine Besylate and Olmesartan Medoxomil in Patients With Hypertension

S. Oparil, M. Melino, S. Chrysant, 2009, Journal of clinical hypertension.

Efficacy and tolerability of amlodipine plus olmesartan medoxomil in patients with difficult-to-treat hypertension

M. Melino, S. Chrysant, R. Heyrman, 2010, Journal of Human Hypertension.

The combination of olmesartan medoxomil and amlodipine besylate in controlling high blood pressure: COACH, a randomized, double-blind, placebo-controlled, 8-week factorial efficacy and safety study.

M. Melino, S. Chrysant, James Lee, 2008, Clinical therapeutics.

24-HOUR EFFICACY AND SAFETY OF FULL-DOSE, TRIPLE-COMBINATION THERAPY WITH OLMESARTAN, AMLODIPINE, AND HYDROCHLOROTHIAZIDE: THE TRINITY STUDY: PP.5.174

J. Izzo, M. Melino, James Lee, 2010 .

24‐Hour Efficacy and Safety of Triple‐Combination Therapy With Olmesartan, Amlodipine, and Hydrochlorothiazide: The TRINITY Ambulatory Blood Pressure Substudy

S. Oparil, D. Kereiakes, M. Melino, 2011, Journal of clinical hypertension.

Efficacy and tolerability of amlodipine plus olmesartan medoxomil in patients with difficult-to-treat hypertension

M. Melino, S. Chrysant, R. Heyrman, 2010, Journal of Human Hypertension.

Efficacy and safety of triple-combination therapy with olmesartan, amlodipine, and hydrochlorothiazide in study participants with hypertension and diabetes: a subpopulation analysis of the TRINITY study.

S. Oparil, J. Izzo, D. Kereiakes, 2012, Journal of the American Society of Hypertension : JASH.

Bioabsorbable Intracoronary Matrix for Prevention of Ventricular Remodeling After Myocardial Infarction.

J. López-Sendón, V. Guetta, N. Frey, 2016, Journal of the American College of Cardiology.